title: CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma.
abstract: The mutation status of genes involved in the NF-κB signaling pathway in splenic marginal zone lymphoma was examined. DNA sequence analysis of four genes was performed: CD79A, CD79B, CARD11, and MYD88 that are activated through BCR signaling or Toll-like and interleukin signaling. A single point mutation was detected in the CD79B gene (Y196H) in one of ten SMZL cases. Additionally, one point mutation was identified in the MYD88 gene (L265P) in another SMZL case. No mutations were revealed in CD79A or CARD11 genes in these SMZL cases. Neither were mutations detected in these four genes studied in 13 control MZL samples. Interestingly, the two cases with mutations of CD79B and MYD88 showed increased numbers of immunoblasts spread among the smaller and typical marginal zone lymphoma cells. Although SMZL shows few mutations of NF-κB signaling genes, our results indicate that the presence of these mutations is associated with a higher histological grade.
authors: Department of Pathology, Oslo University Hospital, The Norwegian Radium Hospital, 0310 Oslo, Norway.
authors: Gunhild
authors: G
authors: Trøen
authors: Abdirashid
authors: A
authors: Warsame
authors: Jan
authors: J
authors: Delabie
references: Nature. 2000 Feb 3;403(6769):503-11
references: 10676951
references: Anticancer Res. 2009 May;29(5):1811-6
references: 19443409
references: Haematologica. 2012 Apr;97(4):595-8
references: 22102703
references: J Clin Invest. 2003 Feb;111(4):529-37
references: 12588891
references: Blood. 2002 Feb 15;99(4):1299-304
references: 11830479
references: Nature. 2009 Jun 4;459(7247):717-21
references: 19412164
references: Hematology Am Soc Hematol Educ Program. 2008;:359-64
references: 19074110
references: Nature. 2010 Jan 7;463(7277):88-92
references: 20054396
references: Blood. 2007 Apr 1;109(7):2700-7
references: 17119127
references: Blood. 2011 Nov 3;118(18):4930-4
references: 21881048
references: Blood. 2009 May 14;113(20):4918-21
references: 19258598
references: J Exp Med. 2001 Dec 17;194(12):1861-74
references: 11748286
references: Mol Med. 2004 Jul-Dec;10(7-12):89-95
references: 15706403
references: Nature. 2011 Feb 3;470(7332):115-9
references: 21179087
references: Science. 2008 Mar 21;319(5870):1676-9
references: 18323416
references: Blood. 2005 Sep 1;106(5):1831-8
references: 15914563